{Reference Type}: Editorial
{Title}: The new life of ibrutinib therapy in CLL: enhancing personalized approaches.
{Author}: Molica S;Mauro FR;
{Journal}: Expert Rev Anticancer Ther
{Volume}: 24
{Issue}: 9
{Year}: 2024 Sep 15
{Factor}: 3.627
{DOI}: 10.1080/14737140.2024.2379921